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Abstract
OBJECTIVE—To describe prepregnancy smoking, pre-natal smoking, and prenatal cessation 
among women reporting and not reporting depression or anxiety.
METHODS—We analyzed cross-sectional data from the 2009–2011 Pregnancy Risk Assessment 
Monitoring System, a population-based survey of women with live births (N=34,633). Smoking 
status was defined as self-reported prepregnancy smoking (during the 3 months before pregnancy), 
prenatal smoking (during the last 3 months of pregnancy), and prenatal cessation (no smoking by 
the last 3 months among prepregnancy smokers). Depression and anxiety status was self-reported 
of having either condition or both during the 3 months before pregnancy. We compared smoking 
prevalence by self-reported depression and anxiety status using χ2 tests and adjusted prevalence 
ratios.
RESULTS—Overall, 16.9% of women in our sample reported depression, anxiety, or both during 
the 3 months before pregnancy. Compared with those who did not report, women who reported 
depression or anxiety had significantly higher prepregnancy (46.7% compared with 22.5%, P<.01) 
and prenatal smoking (27.5% compared with 10.5%, P<.01). A lower proportion of prepregnancy 
smokers who reported depression or anxiety quit smoking by the last 3 months of pregnancy than 
those who did not report (41.4% compared with 53.8%, P<.01). In adjusted analyses, women 
reporting depression or anxiety were 1.5 and 1.7 times more likely to smoke prepregnancy and 
prenatally, respectively, and less likely to quit smoking (adjusted prevalence ratio 0.86, 95% 
confidence interval 0.80–0.92).
CONCLUSION—Women who reported depression, anxiety, or both were more likely to smoke 
before and during pregnancy and less likely to quit smoking during the prenatal period. Screening 
recommendations for perinatal depression and anxiety provide an opportunity to identify a 
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subpopulation of women who may have a higher prevalence of smoking and to provide effective 
tobacco cessation interventions and mental health care.
Approximately 1 of 10 (11.6%) pregnant women smoke in the last 3 months of pregnancy,1,2 
which is far from the Healthy People 2020 objective of decreasing smoking to 1.4%.3 
Subgroups with high smoking prevalence include young women, those with lower 
socioeconomic status, substance users, and those with comorbid mental health disorders.4–6 
Clinical recommendations have included routine tobacco use screening at every prenatal 
care visit,7 and the American College of Obstetricians and Gynecologists recommends that 
clinicians screen all pregnant women for depression and anxiety symptoms.8
Few population-based studies exist examining the associations between smoking and mental 
health status around the time of pregnancy. A few studies have reported a significant 
association between postpartum depression and anxiety and postpartum smoking and 
relapse.9–11 An analysis of a 2001–2002 national sample of women who became pregnant in 
the past year found independent associations between nicotine dependence and major 
depression, dysthymia, and panic disorder.5 However, it is unclear how depression and 
anxiety are associated with smoking before and during pregnancy. The extent to which 
pregnant women reporting depression or anxiety smoke can inform tobacco cessation 
efforts.
We examined prepregnancy smoking, prenatal smoking, and smoking cessation by 
depression and anxiety status and whether smoking differed by health insurance coverage. 
Health coverage for smoking cessation and depression treatments may now be covered in 
Medicaid and insurance plans.12–15 Finally, we assessed whether reported depression and 
anxiety status is independently associated with smoking before and during pregnancy.
MATERIALS AND METHODS
We analyzed cross-sectional data from the 2009–2011 Pregnancy Risk Assessment 
Monitoring System, which is a state- and population-based surveillance system among 
women who deliver liveborn neonates in the United States. The Pregnancy Risk Assessment 
Monitoring System collects data on maternal attitudes and experiences before, during, and 
shortly after pregnancy. The Pregnancy Risk Assessment Monitoring System methodology 
has been described elsewhere.16 Briefly, at each site, a monthly stratified sample of 100–300 
new mothers is selected systematically from birth certificates, and these women are 
contacted by mail. Attempts are made to interview women by phone after nonresponse to 
repeated mailings. The Pregnancy Risk Assessment Monitoring System survey is completed 
at 2–6 months after delivery. Data are weighted to represent all women who delivered live 
births in each site. Of the 40 states and New York City that participated in the Pregnancy 
Risk Assessment Monitoring System during the study period, our study included nine states 
(Delaware, Hawaii, Maryland, Michigan, Minnesota, Missouri, Utah, West Virginia, and 
Wyoming) that queried women about depression and anxiety during the 3 months before 
pregnancy and achieved an overall weighted response rate of 65% or greater for each state 
and year in the study period. The Pregnancy Risk Assessment Monitoring System protocol 
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was reviewed and approved by an institutional review board at the Centers for Disease 
Control and Prevention and each participating state.
We ascertained smoking status in the following way: women who reported that they smoked 
any amount in the past 2 years were asked how many cigarettes they smoked per day on 
average during the 3 months before pregnancy and in the last 3 months of pregnancy. 
Categorical response options were none (0 cigarettes), less than 1, 1–5, 6–10, 11–20, 21–40, 
or 41 or more. In this study, prepregnancy smoking was defined as smoking any cigarettes in 
the 3 months before pregnancy. Prenatal smoking was defined as smoking any cigarettes in 
the last 3 months of pregnancy. Smoking cessation by the last 3 months of pregnancy was 
defined as smoking “none” in the last 3 months of pregnancy among prepregnancy smokers.
Depression and anxiety status was defined by an affirmative response to either or both of the 
following questions: “During the 3 months before you got pregnant, did you have anxiety?” 
and “During the 3 months before you got pregnant, did you have depression?”
Other covariates included in the analysis were maternal age; race and ethnicity; education; 
marital status; parity; state and neonatal birth year obtained from the linked birth certificate 
and health insurance coverage before pregnancy; health insurance coverage during prenatal 
care or at delivery; participation in the Special Supplemental Nutrition Program for Women, 
Infants, and Children; alcohol binge drinking in 3 months before pregnancy and during the 
last 3 months of pregnancy; and physical abuse by a partner in the 12 months before 
pregnancy and during pregnancy were obtained from the Pregnancy Risk Assessment 
Monitoring System survey.
Data from the nine Pregnancy Risk Assessment Monitoring System states used in the study 
include 37,419 women. We excluded records with missing data on smoking (n=513), 
depression or anxiety(n=449), both smoking and depression or anxiety (n=29), and 
covariates (n=1,795), leaving 34,633 for analysis (92.6% of total sample). The 
characteristics of the sample were described by depression and anxiety status. Prevalence 
and 95% confidence intervals (CIs) of prepregnancy smoking, prenatal smoking, and 
smoking cessation were calculated by depression and anxiety status overall and by selected 
maternal characteristics, including health insurance coverage. Chi square tests at P<.05 were 
used to assess differences. Unadjusted and adjusted prevalence ratios of smoking status by 
depression and anxiety status were calculated per methodology by Bieler et al17 controlling 
for all covariates. Analyses were conducted using SAS 9.3 and SUDAAN 11 to account for 
the complex survey design of the Pregnancy Risk Assessment Monitoring System.
RESULTS
For the total study sample (N=34,633), the majority of women were aged 25–34 years 
(56.2%), were non-Hispanic white (68.6%), had greater than 12 years of education (61.7%), 
were married (63.7%), were multiparous (58.1%), had private insurance before pregnancy 
(62.8%), and were not Special Supplemental Nutrition Program for Women, Infants, and 
Children participants (56.0%). Overall, 16.9% (95% CI 16.3–17.4, n=5,769) of women 
reported depression, anxiety, or both during the 3 months before pregnancy (Table 1); 4.7% 
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of women reported anxiety only, 4.3% depression only, and 7.9% reported both depression 
and anxiety. Compared with those without depression or anxiety, women with reported 
depression or anxiety were more likely to be younger (24 years or younger); non-Hispanic 
white; have 12 years or less of education; be unmarried; be enrolled in Medicaid insurance 
before pregnancy; participate in Special Supplemental Nutrition Program for Women, 
Infants, and Children during pregnancy; be a binge drinker before pregnancy only; and 
experience physical abuse by a partner before or during pregnancy.
Overall, 26.5% (95% CI 25.9–27.2) of women with a recent live birth reported smoking in 
the 3 months before pregnancy. Women reporting depression or anxiety had significantly 
higher prepregnancy smoking prevalence compared with those not reporting either condition 
(46.7% compared with 22.5%, P<.01) (Fig. 1; Table 2). When examined by subgroups, 
women reporting depression or anxiety had higher prepregnancy smoking prevalence across 
almost all subgroups with the exception of Native Americans or Alaska Natives and women 
who were binge drinkers during pregnancy (Table 2). Depressed or anxious women with the 
highest pre-pregnancy smoking prevalence included those with less than 12 years of 
education (69.5%); younger than 20 years of age (66.4%); those who experienced physical 
abuse before and during pregnancy (66.0%), before pregnancy only (65.1%), and during 
pregnancy only (62.6%); unmarried women (65.2%); and binge drinkers before pregnancy 
only (61.5%). In adjusted analyses, women reporting depression or anxiety were 1.49 times 
more likely to smoke pre-pregnancy than those not reporting either condition (Table 3). 
Prepregnancy smoking prevalence was significantly higher for women reporting depression 
or anxiety compared with those not reporting either condition for all insurance categories 
with the highest smoking prevalence in those reporting depression or anxiety enrolled in 
Medicaid (67.7%) or who were uninsured (61.5%) (Table 4).
Overall, 13.4% (95% CI 12.8–13.9) of women reported smoking in the last 3 months of 
pregnancy. Women reporting depression or anxiety had significantly higher prenatal 
smoking prevalence compared with those not reporting either condition (27.5% compared 
with 10.5%, P<.01) (Fig. 1; Table 2). When examined by subgroups, women reporting 
depression or anxiety had higher prenatal smoking prevalence across all subgroups than 
those not reporting either condition (Table 2). Depressed or anxious women with the highest 
prenatal smoking prevalence included those with less than 12 years of education (49.4%); 
those who experienced physical abuse before and during pregnancy (46.5%) and before 
pregnancy only (46.4%); and unmarried women (41.5%). In adjusted analyses, women 
reporting depression or anxiety were 1.69 times more likely to smoke in the last 3 months of 
pregnancy than those not reporting either condition (Table 3).
Prenatal smoking prevalence was significantly higher for women reporting depression or 
anxiety for all insurance categories except for those who were uninsured. The highest 
prenatal smoking prevalence was among women reporting depression or anxiety enrolled in 
Medicaid (44.8%) or with other insurance (25.8%) (Table 4).
Among prepregnancy smokers, 50.2% (95% CI 48.6–51.7) of women reported smoking 
cessation by the last 3 months of pregnancy. Women reporting depression or anxiety had 
significantly lower proportions of smoking cessation compared with those not reporting 
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either condition (41.4% compared with 53.8%, P<.01) (Fig. 1). After adjustment, 
prepregnancy smokers reporting depression or anxiety were significantly less likely to quit 
smoking by the last 3 months of pregnancy compared with their counterparts (adjusted 
prevalence ratio 0.86, 95% CI 0.80–0.92) (Table 3). The point prevalence for smoking 
cessation was significantly lower for women reporting depression or anxiety enrolled in 
Medicaid compared with those not reported either condition (32.5% compared with 44.5%) 
(Table 4).
DISCUSSION
We found that women who reported depression, anxiety, or both had higher smoking 
prevalence in the 3 months before pregnancy compared with those not reporting either 
condition; almost half of women reporting depression or anxiety reported smoking. Women 
reporting depression or anxiety were more likely to smoke during pregnancy and less likely 
to quit by the last 3 months of pregnancy than those not reporting either condition. 
Subgroups with the highest smoking prevalence include younger women; those with less 
education; married women; enrolled in Special Supplemental Nutrition Program for Women, 
Infants, and Children; and those reporting binge drinking or physical abuse.
Individuals with mental health conditions may perceive tobacco use as an agent to relieve 
stress and anxiety, and some have reported that traditional cessation interventions do not 
address their mental health.18 However, evidence supports that continued smoking can 
worsen mental health conditions19 and tobacco cessation improves mental health conditions. 
In a meta-analysis of 26 longitudinal studies of smokers, tobacco cessation was associated 
with reduced depression, anxiety, and stress and improved mood and quality of life.20
Clinical trials of pregnant smokers have also documented improved mental health status and 
well-being after tobacco cessation.21–23 An incentive-based cessation trial resulted in 
increased cessation among pregnant women with diagnosed depression, and the intervention 
reduced the severity of postpartum depression symptoms.22 Furthermore, smokers with 
mental health conditions are just as motivated to quit as those not reporting mental health 
conditions.24,25 Patients and health care providers should be aware that tobacco cessation 
can contribute to improved mental health and improved pregnancy health.
American College of Obstetricians and Gynecologists guidelines recommend screening for 
perinatal depression and anxiety at least once during the perinatal period8 in addition to 
routine screening for smoking.7,26 Given the high comorbidity between mental health status 
and smoking, preconception, interconception, and prenatal care present opportunities for 
health care providers to offer evidence-based tobacco cessation interventions and mental 
health care. Behavioral interventions are the first-line clinical approach for tobacco cessation 
during pregnancy.7 There is substantial evidence that behavioral cessation interventions 
significantly increase smoking cessation by the end of pregnancy and improve birth 
outcomes.27 Although cessation itself is associated with improved mental health,21–23 more 
research is needed to determine whether interventions that focus on both mental health 
conditions and smoking may improve both outcomes even further.21,28 Ideally, for smokers 
with mental health conditions, tobacco cessation treatment should be conducted in 
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conjunction with treatment or referral for depression or anxiety.8 At minimum, all smokers 
before and during pregnancy should be offered standard-of-care tobacco cessation 
counseling, and women reporting depression or anxiety may need additional cessation 
support. Depressed or anxious women who reported physical abuse or binge drinking had 
very high smoking prevalence, suggesting also a need to screen and provide support for 
intimate partner violence and alcohol abuse.
We reported that smoking was more common among women reporting depression or anxiety 
regardless of health insurance coverage. Two thirds of Medicaid-enrolled women who 
reported depression or anxiety smoked before pregnancy and 45% smoked in the last 3 
months of pregnancy. Currently, state Medicaid programs are required to provide 
comprehensive tobacco cessation treatment to pregnant smokers, and almost all meet this 
mandate.29 Increased awareness and broad promotion of tobacco cessation benefits can 
increase cessation treatment utilization.30,31 Additionally, all state programs provide at least 
some mental health services to Medicaid beneficiaries,15 and many states offer coverage of 
depression screening and treatment for pregnant women.32 Most individual and small group 
health insurance plans and Medicaid Alternative Benefit Plans are required to cover mental 
health and substance use disorder services.15
This analysis has limitations. First, smoking status was self-reported. Although the 
Pregnancy Risk Assessment Monitoring System ascertains more smokers than other 
population-based sources relying on self-report,33 our results may underestimate the true 
prevalence.34 Second, depression and anxiety were also self-reported, and the Pregnancy 
Risk Assessment Monitoring System does not collect data on clinical diagnosis or treatment 
for these conditions. However, the self-reported estimates of depression (12.2%) and anxiety 
(12.5%) in the 3 months before pregnancy are consistent with estimates based on self-
reported symptoms meeting Diagnostic and Statistical Manual of Mental Disorders, 4th 
Edition diagnostic criteria of depression (8–11%) and anxiety (12–15%) in pregnant and 
nonpregnant women.35,36 Third, the study is cross-sectional so a causal association cannot 
be assessed for smoking or depression and anxiety. Finally, results may not be generalizable 
to women outside of the study states, to those with pregnancy loss, nor outside of the study 
period.
In conclusion, health care providers have an opportunity to identify and treat reproductive-
aged women with tobacco cessation interventions and mental health care. Health care 
providers should inform patients that tobacco cessation may improve pregnancy outcomes 
and maternal mental health status. All smokers should be offered cessation counseling, and 
women reporting depression or anxiety may need additional cessation support.
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Prevalence of smoking by reported depression or anxiety status (N=34,633). Sample 
includes 9 PRAMS (Pregnancy Risk Assessment Monitoring System) states in 2009–2011: 
Delaware, Hawaii, Maryland, Michigan, Minnesota, Missouri, Utah, West Virginia, and 
Wyoming. Smoking in the 3 months before pregnancy: 46.7% (95% CI 44.8–48.6), 22.5% 
(95% CI 21.8–23.2); Smoking in the last 3 months of pregnancy: 27.5% (95% CI 25.8–
29.2), 10.5% (95% CI 10.0–11.0); and smoking cessation by last 3 months of pregnancy: 
41.4% (95% CI 38.6–44.3), 53.8% (95% CI 52.0–55.6). *Difference in smoking status 
between women reporting depression or anxiety and those not reporting based on chi-square 
test, P < .05. †Smoking cessation calculated among women who reported smoking in the 3 
months before pregnancy.
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Table 1
Characteristics of the Sample by Reported Depression and Anxiety Before Pregnancy (N=34,633)*
Characteristic
Depression or Anxiety (Unweighted 
n=5,769)
No Depression or Anxiety (Unweighted 
n=28,864) P†
Total‡ 16.9 (16.3–17.4) 83.1 (82.6–83.7)
Maternal age (y) <.001
 Younger than 20 9.6 (8.5–10.9) 7.6 (7.2–8.1)
 20–24 26.8 (25.1–28.5) 22.1 (21.4–22.8)
 25–34 53.2 (51.3–55.1) 56.9 (56.1–57.7)
 35 or older 10.4 (9.4–11.4) 13.4 (12.9–13.9)
Maternal race and ethnicity <.001
 Non-Hispanic white 77.3 (75.7–78.8) 66.8 (66.1–67.6)
 Non-Hispanic black 10.8 (9.7–12.0) 14.8 (14.2–15.3)
 Hispanic 6.7 (5.8–7.7) 9.4 (8.9–9.9)
 Native American or Alaska Native 1.0 (0.7–1.3) 0.5 (0.5–0.6)
 Asian or Pacific Islander 1.6 (1.3–2.0) 6.0 (5.7–6.3)
 Other race 2.7 (2.1–3.4) 2.5 (2.2–2.8)
Maternal education (y) <.001
 Less than 12 19.3 (17.7–20.9) 12.3 (11.8–12.9)
 12 27.7 (26.0–29.4) 24.3 (23.6–25.0)
 Greater than 12 53.0 (51.1–54.9) 63.4 (62.6–64.2)
Marital status <.001
 Unmarried 47.1 (45.2–49.1) 34.0 (33.3–34.8)
 Married 52.9 (50.9–54.8) 66.0 (65.2–66.7)
Parity <.344
 1 or more 59.0 (57.1–60.9) 58.0 (57.2–58.8)
 0 41.0 (39.1–42.9) 42.0 (41.2–42.8)
Health insurance coverage before pregnancy <.001
 Private 52.0 (50.1–53.9) 64.9 (64.1–65.7)
 Medicaid 24.4 (22.8–26.1) 13.6 (13.1–14.2)
 Other insurance 2.8 (2.2–3.4) 2.2 (2.0–2.5)
 Uninsured 20.8 (19.3–22.5) 19.2 (18.5–19.9)
WIC during pregnancy <.001
 Yes 55.3 (53.4–57.2) 41.7 (40.9–42.5)
 No 44.7 (42.8–46.6) 58.3 (57.5–59.1)
Binge drinking before or during pregnancy <.001
 None 65.4 (63.5–67.2) 75.5 (74.8–76.2)
 Before pregnancy only 33.9 (32.1–35.8) 23.7 (23.0–24.4)
 During pregnancy 0.7 (0.5–1.0) 0.8 (0.7–1.0)
Physical abuse before or during pregnancy <.001
 None 90.2 (89.0–91.3) 96.8 (96.5–97.1)
 During pregnancy only 3.2 (2.6–4.0) 1.2 (1.0–1.4)
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Characteristic
Depression or Anxiety (Unweighted 
n=5,769)
No Depression or Anxiety (Unweighted 
n=28,864) P†
 Before pregnancy only 1.9 (1.4–2.5) 0.8 (0.7–0.9)
 During and before pregnancy 4.7 (3.9–5.6) 1.2 (1.0–1.4)
WIC, Special Supplemental Nutrition Program for Women, Infants, and Children.
Data are % (95% confidence interval) unless otherwise specified.
*
Sample includes nine Pregnancy Risk Assessment Monitoring System states in 2009–2011: Delaware, Hawaii, Maryland, Michigan, Minnesota, 
Missouri, Utah, West Virginia, and Wyoming.
†
Differences based on χ2, P<.05.
‡
Row percentages provided.
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Table 2
Smoking Prevalence Before and During Pregnancy by Reported Depression or Anxiety Status*
Characteristic










No Depression or 
Anxiety (Unweighted 
n=28,864)
Total 46.7 (44.8–48.6) 22.5 (21.8–23.2) 27.5 (25.8–29.2) 10.5 (10.0–11.0)
Maternal age (y)
 Younger than 20†‡ 66.4 (60.4–72.0) 32.3 (29.4–35.3) 40.2 (34.1–46.7) 15.4 (13.3–17.9)
 20–24†‡ 60.0 (56.2–63.6) 33.7 (32.0–35.5) 37.3 (33.7–41.0) 16.6 (15.3–18.0)
 25–34†‡ 40.6 (38.0–43.2) 19.1 (18.3–20.1) 22.6 (20.5–24.9) 8.6 (8.0–9.3)
 35 or older†‡ 25.5 (21.5–30.0) 12.3 (11.0–13.8) 15.0 (11.8–18.8) 5.6 (4.7–6.7)
Maternal race and ethnicity
 Non-Hispanic white†‡ 47.7 (45.5–49.9) 24.9 (24.0–25.8) 28.8 (26.8–30.9) 12.0 (11.3–12.7)
 Non-Hispanic black†‡ 46.3 (40.7–52.0) 20.3 (18.6–22.1) 26.8 (22.4–31.8) 9.8 (8.7–11.1)
 Hispanic†‡ 33.1 (26.4–40.6) 12.3 (10.5–14.4) 14.5 (10.4–20.1) 3.7 (2.8–5.0)
 Native American or Alaska Native‡ 68.2 (50.6–81.8) 51.9 (42.9–60.8) 40.5 (25.8–57.1) 20.0 (14.3–27.2)
 Asian or Pacific Islander†‡ 34.4 (24.6–45.6) 13.3 (11.7–15.2) 13.6 (7.7–22.9) 4.2 (3.4–5.3)
 Other race†‡ 52.6 (40.6–64.3) 23.9 (19.2–29.3) 26.6 (17.6–38.1) 12.7 (9.2–17.3)
Maternal education (y)
 Less than 12†‡ 69.5 (65.0–73.6) 35.8 (33.4–38.2) 49.4 (44.7–54.0) 22.9 (20.9–25.1)
 12†‡ 56.4 (52.8–59.9) 35.7 (34.0–37.3) 35.0 (31.6–38.5) 19.1 (17.8–20.5)
 Greater than 12†‡ 33.4 (31.0–35.8) 14.8 (14.1–15.6) 15.6 (13.8–17.5) 4.8 (4.0–5.3)
Marital status
 Unmarried†‡ 65.2 (62.4–68.0) 38.9 (37.5–40.4) 41.3 (38.5–44.2) 21.3 (20.1–22.5)
 Married†‡ 30.2 (27.9–32.6) 14.0 (13.3–14.7) 15.1 (13.4–17.0) 4.9 (4.5–5.4)
Parity
 1 or more†‡ 46.3 (43.8–48.7) 21.2 (20.3–22.1) 29.1 (26.9–31.4) 11.4 (10.7–12.1)
 0†‡ 47.3 (44.3–50.4) 24.2 (23.1–25.4) 25.1 (22.5–27.8) 9.3 (8.6–10.1)
WIC during pregnancy
 Yes†‡ 59.9 (57.3–62.4) 33.2 (31.9–34.4) 38.6 (36.0–41.2) 18.0 (17.0–19.0)
 No†‡ 30.5 (28.0–33.2) 14.8 (14.0–15.6) 13.7 (11.9–15.8) 5.1 (4.7–5.6)
Binge drinking before or during 
pregnancy
 None†‡ 39.0 (36.7–41.3) 15.9 (15.2–16.6) 24.8 (22.8–26.9) 8.2 (7.7–8.7)
 Before pregnancy only†‡ 61.5 (58.2–64.8) 43.1 (41.4–44.9) 32.5 (29.3–35.7) 17.7 (16.3–19.1)
 During pregnancy‡ 47.5 (29.7–66.0) 30.8 (23.0–39.8) 36.5 (22.0–54.0) 17.2 (11.6–24.6)
Physical abuse before or during 
pregnancy
 None†‡ 44.5 (42.5–46.6) 21.7 (21.0–22.4) 25.7 (23.9–27.5) 10.1 (9.6–10.6)
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Characteristic










No Depression or 
Anxiety (Unweighted 
n=28,864)
 During pregnancy only†‡ 62.6 (51.5–72.5) 48.3 (40.6–56.1) 39.4 (29.7–50.1) 22.0 (16.3–29.0)
 Before pregnancy only†‡ 65.1 (49.8–77.8) 34.8 (26.9–43.6) 46.4 (31.7–61.8) 18.4 (12.7–25.9)
 During and before pregnancy†‡ 66.0 (56.5–74.3) 44.5 (37.0–52.2) 46.5 (37.7–55.6) 24.2 (18.6–30.9)
WIC, Special Supplemental Nutrition Program for Women, Infants, and Children.
Data are % (95% confidence interval).
*
Sample includes nine Pregnancy Risk Assessment Monitoring System states in 2009–2011: Delaware, Hawaii, Maryland, Michigan, Minnesota, 
Missouri, Utah, West Virginia, and Wyoming.
†
Difference in smoking prevalence in the 3 months before pregnancy between women reporting depression or anxiety and those not reporting based 
on χ2 test, P<.05.
‡
Difference in smoking prevalence in the last 3 months of pregnancy between women reporting depression or anxiety and those not reporting based 
on χ2 test, P<.05.
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Table 3
Association Between Reported Smoking and Depression or Anxiety Status (N=34,633)*
Crude Prevalence Ratio (95% CI) Adjusted Prevalence Ratio (95% CI)
Smoked in the 3 mo before pregnancy
 Depression or anxiety 2.08 (1.97–2.19) 1.49 (1.41–1.57)†
 None Reference Reference
Smoked in the last 3 mo of pregnancy
 Depression or anxiety 2.62 (2.42–2.84) 1.69 (1.56–1.84)‡
 None Reference Reference
Smoking cessation by the last 3 mo of pregnancy§
 Depression or anxiety 0.77 (0.71–0.83) 0.86 (0.80–0.92)||
 None Reference Reference
CI, confidence interval.
*
Nine Pregnancy Risk Assessment Monitoring System states in 2009–2011: Delaware, Hawaii, Maryland, Michigan, Minnesota, Missouri, Utah, 
West Virginia, and Wyoming.
†
Adjusted for maternal age, race and ethnicity, education, marital status, insurance coverage before pregnancy, parity, alcohol use or binge drinking 
before pregnancy, physical abuse before and during pregnancy, state and year of neonatal birth.
‡
Adjusted for maternal race and ethnicity, education, marital status, insurance coverage during prenatal care and at delivery, parity, physical abuse 
before and during pregnancy, and state (n=33,492).
§
Smoking cessation by the last 3 months of pregnancy was calculated among prepregnancy smokers only.
||
Adjusted for maternal race and ethnicity, education, marital status, insurance coverage before pregnancy, parity, physical abuse before and during 
pregnancy, and state (n=9,350).
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Table 4
Reported Smoking Prevalence by Depression or Anxiety Status and Health Insurance Coverage*
Health Insurance Coverage
Type of Health Insurance Coverage









 Smoked in the 3 mo before pregnancy (N=34,633)‡§||¶
  Depression or anxiety 30.3 (27.9–32.9) 67.7 (64.0–71.3) 56.2 (45.5–66.3) 61.5 (57.2–65.6)
  None 15.7 (14.9–16.5) 35.4 (33.2–37.6) 22.4 (18.3–27.1) 35.6 (33.7–37.5)








 Smoked in the last 3 mo of pregnancy (n=33,733)‡§||
  Depression or anxiety 11.1 (9.5–13.0) 44.8 (41.9–47.7) 25.8 (17.6–36.2) 15.3 (7.7–28.1)
  None 5.2 (4.8–5.8) 21.1 (19.9–22.4) 9.0 (6.6–12.1) 5.4 (3.7–8.0)
 Smoking cessation by the last 3 mo of pregnancy (n=9,342)§
  Depression or anxiety 61.5 (56.3–66.4) 32.5 (29.2–36.0) 48.4 (33.4–63.7) 41.1 (20.3–65.6)
  None 66.0 (63.2–68.6) 44.5 (42.0–47.0) 60.5 (50.5–69.7) 53.5 (40.0–66.5)
*
Nine Pregnancy Risk Assessment Monitoring System states in 2009–2011: Delaware, Hawaii, Maryland, Michigan, Minnesota, Missouri, Utah, 
West Virginia, and Wyoming.
†
Other health insurance coverage includes Tricare, other military insurance, Indian Health Services, or state-specific State Children’s Health 
Insurance Programs or Children’s Health Insurance Program.
‡
Difference between smoking status by depression or anxiety and those not reporting either condition for privately insured women, based on χ2 
test, P<.05.
§
Difference between smoking status by depression or anxiety and those not reporting either condition for Medicaid-insured women, based on χ2 
test, P<.05. 
||
Difference between smoking status by depression or anxiety and those not reporting either condition for women with other insurance, based on χ2 
test, P<.05.
¶
Difference between smoking status by depression or anxiety and those not reporting either condition for uninsured women, based on χ2 test, P<.
05.
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